Publications

255 publications

Enter search criteria

Fill in keyword(s) to narrow your search.

Periode

Enter a start and/or end date here, using the following format: DD-MM-YYYY.

You can select a specific type of a publication you are looking for, such as press releases or speeches

Idebenone (Raxone®) for the treatment of Leber’s Hereditary Optic Neuropathy (LHON)

Zorginstituut Nederland has carried out an assessment of the medicinal product idebenone (Raxone®). Idebenone (Raxone®) is not ...

Report | 20-10-2017

Programme ‘Outcome Information for Shared Decision-Making’ - factsheet

Publication | 19-10-2017

Project: ‘ICHOM as an accelerator for outcome information’ - factsheet

Publication | 19-10-2017

Glycerol phenylbutyrate (Ravicti®) for the treatment of urea-cycle disorders

Zorginstituut Nederland has carried out an assessment of the medicinal product glycerol phenylbutyrate (Ravicti®) for the ...

Report | 12-09-2017

Zinnige Zorg room for improvement report - In-depth phase neoplasms: care during the final stage of life of patients with incurable intestinal or lung cancer

The final stage of life is one in which a patient is of an advanced age or has a disease and/or is in a phase of a disease that ...

Report | 01-09-2017

Cetuximab (Erbitux®) for the treatment of metastatic colorectal cancer

Zorginstituut Nederland has carried out a re-assessment of the medicinal product cetuximab (Erbitux®), whereby they came to the ...

Report | 26-06-2017

Acarizax® in cases of allergic rhinitis due to house dust mite

Zorginstituut Nederland carried out an assessment of whether the medicinal product Acarizax® is interchangeable with a drug ...

Report | 26-06-2017

A paradigm shift in perception, learning and action - core of the second advice of the Committee Innovation Health Care Professions & Education

Translation of the core of the second advice of The Committee Innovation Health Care Professions & Education.

Report | 18-05-2017

Tenofovir alafenamide (Vemlidy®) for the treatment of chronic hepatitis B infection

Zorginstituut Nederland carried out an assessment of the medicine tenofovir alafenamide (Vemlidy®). Based on the criteria of the ...

Report | 26-04-2017

Migalastat (Galafold®) for the treatment of Fabry's disease

Zorginstituut Nederland carried out an assessment of whether, based on the criteria of the Medicines Reimbursement System (GVS), ...

Report | 25-04-2017